Advanced Search
Contact | Corporate | Help

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Sponsors:
  • Memorial Sloan-Kettering Cancer Center
  • Genentech
  • Children's Mercy Hospital Kansas City
  • Penn State University
  • University of Colorado Health Sciences Center and The Children's Hospital
  • Johns Hopkins Medical Center Sidney Kimmel Comprehensive Cancer Center
  • P
Phases:
  • Phase II
IndicationsAcronym:
  • Neuroblastoma
  • Sarcoma
Age Groups:
  • Child
  • Adult
Gender:
Both
Names:
  • Drug: Cyclophosphamide, Topotecan, and Bevacizumab
Enrollment:
10

Additional information about NCT01492673.


SourceSolution © 2008-2012